Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients

Status:
Completed

Trial end date:
2012-02-01

Target enrollment:

Participant gender:

The study will assess the efficacy, safety and tolerability of AZD1981 compared to non-active compound in asthmatic patients.

Phase 2

AstraZeneca